Telemetry Investments’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Telemetry Investments’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,500	Closed	-$885K	–	199
2022 Q2	$780K	Sell	10,500 -500	-5%	-$37.5K	0.92%	21
2022 Q1	$989K	Buy	11,000 +1,000	+10%	+$92.3K	1.56%	13
2021 Q4	$1.12M	Buy	+10,000	New	+$1.21M	1.44%	13
2017 Q3	–	Sell	-4,000	Closed	-$321K	–	155
2017 Q2	$309K	Buy	+4,000	New	+$284K	0.15%	86

Other funds holding XBI

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

MCM

Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

APF

Alaska Permanent Fund Juneau, Alaska $1.51B AUM 22.23% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Telemetry Investments's XBI Position: Q3 2022 in Review

Telemetry Investments sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2022, closing a stake of 10,500 shares — an estimated $885K sold.

Telemetry Investments first reported a position in XBI in Q2 2017 and held it in 4 quarters. The position peaked at $1.12M in Q4 2021. 703 funds tracked by Wall St. Rank hold XBI as of Q3 2022.

Telemetry Investments reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2022 after selling out during the quarter.
Telemetry Investments sold 10,500 State Street SPDR S&P Biotech ETF shares in Q3 2022, an estimated $885K.
Telemetry Investments first reported a position in State Street SPDR S&P Biotech ETF in Q2 2017 and held it in 4 quarters.
Telemetry Investments's State Street SPDR S&P Biotech ETF position peaked at $1.12M in Q4 2021.
703 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2022.

Based on Telemetry Investments's 13F filing for Q3 2022, filed 17 Nov 2022.